Qutem
Qutem AB provides GMP-certified transmission electron microscopy services and quality control analyses for gene therapy developers, using proprietary Gridsee image analysis software. The Stockholm-based company serves US biotech clients via a satellite lab at Boston University.
- Company typePrivate
- Founded-
- HeadquartersStockholm, Sweden
- Headcount11–50
- GTM typeB2B
- OfferingServices
What Qutem does
QuTEM AB is a Swedish specialty laboratory services company providing GMP-certified transmission electron microscopy (TEM) services and quality control analyses for gene therapy developers. The company combines physical imaging operations with a proprietary image analysis software platform called Gridsee, which standardizes analytical procedures and produces comparable outputs across sample sites. Its primary customers are US-based enterprise gene therapy developers, a segment that historically lacked localized access to GMP-certified TEM quality control and faced transatlantic shipping and customs delays when sending samples to European providers.
QuTEM's business model is a hybrid of professional services and recurring software access. Sample preparation and imaging can be performed at the company's US satellite laboratory located at Boston University's Cryogenic Electron Microscopy Core Facility, with images securely transferred to QuTEM's Stockholm headquarters for centralized analysis. The Stockholm headquarters houses the core analytical team and Gridsee operations, while the Boston partnership provides a capital-light entry into the North American market without requiring QuTEM to own US laboratory infrastructure. The company is privately held, employs between 11 and 50 people, and has no disclosed funding history or revenue figures.
The company is actively operating and accepting new US clients following the March 2026 launch of its Boston satellite laboratory, which has already completed its first client project. Operating geographies span Sweden and the United States, with the company's competitive positioning centered on regulatory compliance (GMP certification), proprietary analytical software (Gridsee), and elimination of international shipping logistics for time-sensitive gene therapy R&D pipelines.
Qutem firmographics
Firmographics- Name
- Qutem
- Legal name
- QuTEM AB
- Website
- https://qutem.com
- Company type
- Private
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Short description
- Qutem AB provides GMP-certified transmission electron microscopy services and quality control analyses for gene therapy developers, using proprietary Gridsee image analysis software. The Stockholm-based company serves US biotech clients via a satellite lab at Boston University.
- Ownership category
- akta.pro rank
Qutem industry classification
Industry- Product category
- Biopharmaceutical Analytical Services
- NAICS
- Analytical Laboratory Instrument Manufacturing (334516), Navigational, Measuring, Electromedical, and Control Instruments Manufacturing (33451)
- SIC
- Services-Testing Laboratories (8734), Laboratory Analytical Instruments (3826), Services-Commercial Physical & Biological Research (8731)
- akta.pro primary industry
- Gene Therapy Analytical Testing & QC (potency, vg/ddPCR, infectivity, RCL/RCA) (HLAAACAK)
- akta.pro secondary industries
- Quality Control (QC) Testing Technologies for Biomanufacturing (release/stability assays, rapid microbiology) (HLAAAJAK), Analytical Development & QC Testing (Release/Stability/Potency) (HLAGAGAF)
Keywords
Where Qutem is headquartered
LocationHeadquarters
- HQ city
- Stockholm
- HQ country
- Sweden
- HQ region
- Europe
Offices2 records
Markets served
Qutem business model
Business model- GTM type
- B2B
- Offering type
- Services
- Cost components
- Personnel, Technology or R&D, Operations, Infrastructure
Revenue model
- GMP-Certified TEM Services: QuTEM provides transmission electron microscopy services for quality control analysis of gene therapy products. Services include sample imaging and expert analysis delivered through standardized procedures. The company operates satellite laboratories to expand geographic reach while maintaining central analysis capabilities at headquarters.
- Gridsee Software Access: Proprietary Gridsee software is provided as part of the analytical service offering, enabling standardized imaging analysis procedures across client sites.
Go-to-market motion1 record
Distribution channels1 record
Qutem product offering
Product offeringCore offering
QuTEM AB provides GMP-certified transmission electron microscopy (TEM) services for quality control analysis of gene therapy products. The offering combines physical sample preparation and imaging with proprietary Gridsee image analysis software, delivered as standardized analytical services. The company operates a Swedish headquarters for analysis and a U.S. satellite laboratory at Boston University's Cryogenic Electron Microscopy Core Facility for localized sample preparation and imaging of U.S. clients.
Product overview
QuTEM offers a portfolio centered on GMP-certified transmission electron microscopy (TEM) services and quality control analyses for gene therapy developers. The core offering combines proprietary Gridsee software with laboratory operations spanning Sweden and a U.S. satellite facility at Boston University. Customers can access services locally through the Boston partnership or through QuTEM's Swedish headquarters.
Differentiator
Problem solved
Functional benefit
Products and services
- GMP-Certified TEM Services Transmission electron microscopy services providing GMP-certified quality control analyses for gene therapy developers. Services include sample preparation, imaging, and image analysis performed at QuTEM's Swedish headquarters or via the U.S. satellite facility at Boston University's Cryogenic Electron Microscopy Core Facility.
- Gridsee Software Proprietary image analysis software platform used for analyzing transmission electron microscopy images. Provided as part of QuTEM's GMP-certified quality control services for gene therapy developers, enabling standardized analytical procedures across the Stockholm HQ and the Boston satellite lab.
Quantifiable outcome
- Eliminates transatlantic shipping logistics and customs delays
- +1 more outcomes
Companies that use Qutem
Customer profileNamed customers1 record
Segments1 record
Ideal customer profiles1 record
Qutem technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature1 record
Qutem partnerships and signals
Strategic signalPartnerships
One partnership is on record.
- Boston University - Cryogenic Electron Microscopy Core FacilitycoreStrategic partnership establishing QuTEM's first U.S. satellite laboratory at Boston University's Cryogenic Electron Microscopy Core Facility. Boston University scientists perform sample preparation and imaging following QuTEM's standardized procedures. Images are securely transferred to QuTEM's Swedish headquarters for analysis. The collaboration enables U.S.-based gene therapy developers to access QuTEM's analytical services and proprietary Gridsee software locally, eliminating international shipping complexities.
Scale indicators1 record
Recent moves6 records
Expansion highlights4 records
Qutem competitors and assessment
Company assessmentBroad incumbents
- JEOL: JEOL is a major manufacturer of transmission electron microscopes widely used in life sciences. While not a service provider, its instruments are the core platform QuTEM relies on, making it a relevant incumbent in the underlying EM ecosystem.
- Thermo Fisher Scientific: Thermo Fisher manufactures electron microscopes (e.g., Talos, Glacios) and offers analytical services used in biopharma. Its instruments underpin TEM workflows similar to QuTEM's, and its PPD/CDMO arm competes in gene therapy CMC.
- Charles River Laboratories: Charles River is a large CRO with extensive biologics and gene therapy analytical services, including viral clearance and CMC testing. It overlaps with QuTEM's QC testing mission as part of a much broader service portfolio.
- Eurofins Scientific: Eurofins is a global testing services group offering bioanalytical, CMC, and QC services for pharmaceuticals including biologics. It competes with QuTEM as a broad incumbent in outsourced analytical testing for gene therapy developers.
- Catalent: Catalent is a major CDMO offering analytical development and QC services for gene therapies and biologics. It is a broad incumbent that competes with specialized analytics providers like QuTEM within customer CMC workflows.
- Bruker: Bruker provides advanced bio-AFM, electron microscopy, and biophysical characterization tools used in biologics development. Its BioSpin and NanoAnalytics divisions overlap with the high-resolution analytical capabilities QuTEM delivers.
Direct peers
- Vironova: Vironova is a Swedish company providing TEM-based nanoparticle analysis, including services and instruments for gene therapy and vaccine characterization. It is a direct competitor to QuTEM in GMP-certified TEM analytics for viral vectors and complex biologics.
- NanoImaging Services: NanoImaging Services provides cryo-EM and TEM-based characterization for biologics and gene therapy developers in the US. It competes directly with QuTEM's US satellite offering for TEM QC work on AAV and other viral vectors.
Emerging players
- ExonanoRNA: ExonanoRNA is a small French biotech-service hybrid focused on RNA nanoparticle characterization and TEM analysis for therapeutic nucleic acids. It is an emerging peer with niche overlap in TEM-based nanoparticle QC.
- Nanolive: Nanolive offers label-free live cell imaging and analytical microscopy tools for biopharma R&D. It is an emerging player whose technology and target customer base partially overlap with QuTEM's imaging-driven analytical services.
Market position
Strengths4 records
Weaknesses5 records
Competitive moat4 records
Key risks5 records
Key highlights5 records
Customer concentration
Qutem social profiles
Digital presenceQutem compliance and trust
Trust signalCompliance1 record
Qutem financial estimates
Financial estimateRevenue estimate
Valuation estimate
Qutem leadership team
Management profileNumber of profiles
Qutem funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Qutem M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Qutem
What does Qutem do?
QuTEM AB provides GMP-certified transmission electron microscopy (TEM) services for quality control analysis of gene therapy products. The offering combines physical sample preparation and imaging with proprietary Gridsee image analysis software, delivered as standardized analytical services. The company operates a Swedish headquarters for analysis and a U.S. satellite laboratory at Boston University's Cryogenic Electron Microscopy Core Facility for localized sample preparation and imaging of U.S. clients.
Is Qutem a public or private company?
Qutem is a private company. It is classified as unknown and is currently operating.
When was Qutem founded?
Qutem was founded in -1. It employs 11 to 50 people.
Where is Qutem based?
Qutem is headquartered in Stockholm, Sweden, in the Europe region.
How does Qutem make money?
Two revenue lines are on record. GMP-Certified TEM Services are the primary driver. The others are gridsee Software Access.
Who are Qutem's main competitors?
Broad incumbents on record are JEOL, Thermo Fisher Scientific, Charles River Laboratories, Eurofins Scientific, Catalent and Bruker. Direct peers are Vironova and NanoImaging Services. Emerging players are ExonanoRNA and Nanolive.
Does Qutem have an API?
No public API is recorded for Qutem.
What industry is Qutem in?
Qutem's product category is Biopharmaceutical Analytical Services. Its primary akta.pro industry code is HLAAACAK, Gene Therapy Analytical Testing & QC (potency, vg/ddPCR, infectivity, RCL/RCA), with a secondary code of HLAAAJAK, Quality Control (QC) Testing Technologies for Biomanufacturing (release/stability assays, rapid microbiology). Its NAICS code is 334516 and its SIC code is 8734.